These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Electrophysiologic study of propafenon in Wolff-Parkinson-White syndrome]. Clémenty J; Sourdille N; Pedeboscq G; Bricaud H Ann Cardiol Angeiol (Paris); 1982; 31(5):351-5. PubMed ID: 7158983 [No Abstract] [Full Text] [Related]
5. Drug therapy, cardiac pacing and cardiac surgery in the Wolff-Parkinson-White syndrome. Report of two cases treated with cardiac pacemakers. Johnson CD Bol Asoc Med P R; 1977 May; 69(5):160-6. PubMed ID: 267481 [No Abstract] [Full Text] [Related]
7. [Drug therapy of supraventricular and ventricular tachyarrhythmias]. Hohnloser SH Internist (Berl); 1996 Jan; 37(1):45-52. PubMed ID: 8837827 [No Abstract] [Full Text] [Related]
8. The pseudoventricular tachycardias in the Wolff-Parkinson-White syndrome. Johnson CD Bol Asoc Med P R; 1979 Feb; 71(2):34-47. PubMed ID: 287470 [No Abstract] [Full Text] [Related]
9. [Wolff-Parkinson-White syndrome. I. Clinical observations and therapeutic problems]. Musiał WJ; Pracka H; Krzemińska-Pakuła M; Kałuzna J Kardiol Pol; 1980; 23(9):745-53. PubMed ID: 7441944 [No Abstract] [Full Text] [Related]
10. [Differential indications for anti-arrhythmia therapy]. Manz M; Wagner WL; Lüderitz B Internist (Berl); 1987 Mar; 28(3):182-9. PubMed ID: 2438248 [No Abstract] [Full Text] [Related]
11. Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction. Ozaydín M; Varol E; Dogan A; Aslan SM; Altínbas A Minerva Cardioangiol; 2007 Jun; 55(3):427. PubMed ID: 17534262 [No Abstract] [Full Text] [Related]
12. Use of medications in Wolff-Parkinson-White syndrome. Redfearn DP; Krahn AD; Skanes AC; Yee R; Klein GJ Expert Opin Pharmacother; 2005 Jun; 6(6):955-63. PubMed ID: 15952923 [TBL] [Abstract][Full Text] [Related]
13. [Personal experience with the use of Lorcainide in the treatment of Wolff-Parkinson-White syndrome in infants and older children]. Bartáková H; Hrobonová V; Samánek M Cesk Pediatr; 1983 Jul; 38(7):421-6. PubMed ID: 6616696 [No Abstract] [Full Text] [Related]
15. [Effect of the anti-arrhythmia agent ethmozin on the refractory period of the accessory pathway in Wolff-Parkinson-White syndrome]. Rakovec P; Kenda MF Wien Med Wochenschr; 1986 Feb; 136(3):65-6. PubMed ID: 3515775 [TBL] [Abstract][Full Text] [Related]
16. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias]. Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821 [TBL] [Abstract][Full Text] [Related]
17. [Tactics of treatment of patients with arrhythmia]. Glezer MG; Orlov LL Klin Med (Mosk); 1995; 73(4):13-7. PubMed ID: 7474808 [No Abstract] [Full Text] [Related]
18. Pharmacologic therapy with flecainide for asymptomatic Wolff-Parkinson-White syndrome in an infant with severe left ventricular dyssynchrony. Suzuki S; Hokosaki T; Iwamoto M Cardiol Young; 2018 Jul; 28(7):970-973. PubMed ID: 29848398 [TBL] [Abstract][Full Text] [Related]
19. [Wolff-Parkinson-White syndrome. Outcome of patients treated with anti-arrhythmia agents from data of electrophysiological examinations]. Cointe R; Lévy S; Metge M; Bru P; Bricaud H; Gérard R Arch Mal Coeur Vaiss; 1988 Feb; 81(2):171-5. PubMed ID: 3130816 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of ajmalin (gylurritmal) in the treatment of a paroxysmal auricular fibrillation lasting for 3 weeks in a case of W.P.W]. Duclós F Rev Esp Cardiol; 1969; 22(2):240-54. PubMed ID: 5801961 [No Abstract] [Full Text] [Related] [Next] [New Search]